Confidence in a changing market: 2025 dealmaking themes and 2026 market opportunities
In 2025, the global transactional market demonstrated resilience amid sustained complexity. Financing conditions improved selectively, capital markets reopened, and international dealmaking rebounded, with mid-market activity and larger, high‑quality deals driving a measured recovery. Against this backdrop, Osborne Clarke advised on a significant volume of domestic and cross‑border transactions, giving us a front‑row view of the trends shaping corporate and investor behaviour.
This report looks at the dynamics prevalent in the dealmaking market and examines 5 key themes that defined Osborne Clarke’s dealmaking activity in 2025 and will continue to influence transaction strategy in 2026. AI is the defining theme in Tech, Media and Communications, driving record spend on infrastructure, chips, data‑rich platforms and talent, and powering a resurgence in tech M&A, private equity and late‑stage venture. In Energy and Energy Transition, renewables, storage, grid modernisation and emerging technologies such as hydrogen and small modular reactors are reshaping portfolios as corporates and sponsors pursue net‑zero, energy security and supply resilience. In Life Sciences and Healthcare, big pharma, strategic buyers and financial investors are using deals to replenish pipelines, access innovation and scale technology‑enabled care.
Drawing on our experience across these themes, this report is designed to help boards, investors and founders navigate an increasingly complex deal environment and position confidently for the next wave of opportunity in 2026.
Speak to one of our experts.

Cross-border deals rebound globally as regulatory complexity intensifies
Cross‑border transactions are rebounding, led by the US and tech sectors, but rising regulatory, financing and cultural complexity mean early planning and smart structuring are critical for 2026.

AI likely to drive global technology transactions in 2026
AI‑driven tech, media and communications deals boomed in 2025, the trend seems set to carry on into 2026 and digitalisation, automation and cybersecurity will remain compelling investment themes.

Healthcare and life sciences deal activity to accelerate across global markets in 2026
Healthcare and life sciences transactions set to continue 2025 trends, with larger AI‑enabled and specialist deals, strong valuations and heightened regulatory, data and valuation‑gap complexities.
Our experts
Co-head International Corporate Group, Partner, UK
Knowledge Lawyer Director, UK
Co-head International Corporate Group, Partner, Germany
Head of Business Transactions Knowledge, UK
Articles
Cross-border deals rebound globally as regulatory complexity intensifies
AI likely to drive global technology transactions in 2026
Healthcare and life sciences deal activity to accelerate across global markets in 2026
Innovation and renewables will underpin energy transition M&A and investments in 2026
Atlantic crossing: How US acquirers are reshaping dealmaking in Europe
© Osborne Clarke 2026
Privacy Policy Terms and Conditions Cookie Policy
Legal Notice: When you read about Osborne Clarke on this site, we are either referring to our international organisation, Osborne Clarke Verein (OCV), or one of its member firms. OCV is a Swiss verein and doesn’t provide services to clients. The OCV member firms are all separate legal entities and have no authority to obligate or bind each other or OCV with regard to third parties. To find out more, please click here.








